MPZ Gene CMT1B Genetic Test
At DNA Labs UAE, we offer the MPZ Gene CMT1B Genetic Test for individuals suspected of having Charcot-Marie-Tooth disease type 1B (CMT1B), a hereditary neurological disorder affecting the peripheral nerves.
The MPZ gene is associated with CMT1B and is responsible for coding a protein called myelin protein zero, which is crucial for the formation and maintenance of myelin. Myelin is the protective covering surrounding nerve fibers that allows them to transmit electrical signals.
Our MPZ Gene CMT1B Genetic Test utilizes NGS (next-generation sequencing) technology, which enables the analysis of multiple genes simultaneously, including the MPZ gene. This comprehensive testing method helps identify mutations in the MPZ gene that are associated with CMT1B, enabling a precise diagnosis for individuals displaying symptoms of the condition.
Symptoms and Diagnosis
CMT1B is characterized by symptoms such as muscle weakness, loss of sensation in the limbs, and difficulties with coordination and balance. If you have a family history of CMT1B or are experiencing these symptoms, our MPZ Gene CMT1B Genetic Test can provide a conclusive diagnosis.
Test Components and Price
The MPZ Gene CMT1B Genetic Test is available for AED 4400.0. We accept blood samples, extracted DNA, or one drop of blood on an FTA card for testing.
Test Department and Doctor
This test is conducted in our Genetics department and is overseen by a Neurologist.
Pre Test Information
Prior to the test, we recommend providing the clinical history of the patient undergoing the MPZ Gene CMT1B NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to create a pedigree chart of family members affected by MPZ Gene CMT1B.
Report Delivery and Method
After the test is conducted, the report will be delivered within 3 to 4 weeks. The MPZ Gene CMT1B Genetic Test utilizes NGS technology for accurate and efficient analysis.
A positive test result for the MPZ Gene CMT1B Genetic Test confirms a diagnosis of CMT1B, allowing for appropriate treatment and management options to be explored. If you suspect you or a family member may have CMT1B, we encourage you to undergo our comprehensive genetic testing to gain a better understanding of the condition.
|MPZ Gene CMT1B Genetic Test
|Blood or Extracted DNA or One drop Blood on FTA Card o
|3 to 4 Weeks
|Pre Test Information
|Clinical History of Patient who is going for MPZ Gene CMT1B NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MPZ Gene CMT1B
The MPZ gene is associated with Charcot-Marie-Tooth disease type 1B (CMT1B), a hereditary neurological disorder that affects the peripheral nerves. CMT1B is caused by mutations in the MPZ gene, which codes for a protein called myelin protein zero. This protein is essential for the formation and maintenance of myelin, the protective covering that surrounds nerve fibers and allows them to transmit electrical signals.
NGS (next-generation sequencing) is a genetic testing method that can analyze multiple genes at once, including the MPZ gene. This test can identify mutations in the MPZ gene that are associated with CMT1B, providing a diagnosis for individuals with symptoms of the condition.
NGS genetic testing for CMT1B may be recommended for individuals with a family history of the condition or who are experiencing symptoms such as muscle weakness, loss of sensation in the limbs, and difficulty with coordination and balance. A positive test result can confirm a diagnosis of CMT1B and help guide treatment and management options.